Professional resources

These resources are provided to help providers with a variety of patient questions and concerns.

Financial support for patients

Quest Diagnostics offers a reimbursement support program for patients who meet the necessary criteria for testing. Upon receipt of a fully completed order and a patient blood sample, our team will verify coverage of your patient’s plan and quickly determine their likely out-of-pocket responsibility.

In the unlikely event that your patient’s estimated responsibility is over $100 for the Hereditary Breast Cancer Panel or Comprehensive and Guideline-Based Hereditary Cancer Panels, we will attempt to notify you and/or your patient prior to test initiation to discuss options for continuation or cancellation of the test. Please note that cases lacking complete information or a patient blood sample will not be processed, except where required by certain commercial insurance carriers.

Quest Diagnostics will also provide financial assistance as part of our commitment to keep testing affordable. For more information on these services and additional testing resources, please contact Quest Diagnostics at 1.866.GENE.INFO (1.866.436.3463).

Financial Assistance Program

Quest offers an easy-to-use financial assistance program that limits out-of-pocket expense to $200 for qualified patients with income at or below 400% of the federal poverty level for qualified tests. For uninsured and underinsured patients whose income is equal to or below the federal poverty level, testing may be provided at no charge. For patients who require additional financial assistance, Quest Diagnostics offers payment plans of 0% financing for a 12-month period.

The Financial Assistance Program applies to the following tests:

  • Comprehensive Hereditary Cancer Panel
  • Guideline-Based Hereditary Cancer Panel
  • Hereditary Breast Cancer Panel
  • Hereditary Colorectal Cancer Panel
  • Hereditary Endocrine Cancer Panel
  • BRCA Panel Plus
  • BRCA Panel (BRCA1, BRCA2)
  • BRCA Ashkenazi Jewish Screen
  • BRCA Ashkenazi Jewish Screen w/Reflex to BRCA Panel (BRCA1, BRCA2)
  • BRCA1 and BRCA2 Deletion and Duplication
  • Lynch Syndrome Panel
  • Nevoid Basal Cell Carcinoma (NBCCS) (Gorlin) Syndrome Panel (PTCH1, SUFU)
  • Tuberous Sclerosis Complex Panel (TSC1, TSC2)
  • Juvenile Polyposis Panel (BMPR1A, SMAD4)
  • Hereditary Cancer Single site(s) test
  • Hereditary Cancer Single-gene tests

Call 1.866.GENE.INFO (1.866.436.3463) for clinical consultation on test selection and results interpretation